首頁 > 市場調查報告書 > 工業機械

測量儀器生技設備

市場調查報告書

商品編碼

1468711

全球實驗室用品市場：市場規模和份額分析（按產品供應、最終用戶和分銷管道）、產業需求預測（截至 2030 年）

Lab Supplies Market Size and Share Analysis by Based on Offering, End User, Distribution Channel - Global Industry Demand Forecast to 2030

出版日期: 2024年03月01日 | 出版商:

Prescient & Strategic Intelligence | 英文 240 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

市場概況

預計2023年全球實驗室耗材產業市場規模將達403億美元，2030年將達664億美元，複合年增長率為7.6%。

背後的原因包括生命科學公司研發費用的增加、公司數量的增加、傳染病的傳播。

關鍵見解

2023年，在實驗室耗材市場中，設備類別將佔最大份額，達到70%。

此優勢主要源自於製藥和生技公司、研發中心、實驗室和科研機構對此類高品質設備的既定需求。

研發中心在終端用戶領域佔據最大的市場份額，到 2023 年將達到 40%。

這一優勢歸功於生物製藥、製藥和生物技術行業的研究舉措的增加。

北美是該領域的領導者，因為這裡有許多活躍於研發的大型生物製藥、製藥和生物技術公司。

歐洲預計將出現高速成長，因為它擁有相當數量的研究機構，研究經費不斷增加。

本報告分析了全球實驗室耗材市場，包括市場的基本結構和最新情況、主要促進和抑制因素以及全球、按地區和主要國家的市場規模前景（以貨幣形式計算），（2017-2030 ），按產品供應、最終用戶和分銷管道劃分的詳細趨勢、市場競爭的現狀以及主要公司的概況。

摘要
市場收入：依產品分類（2017-2030 年）
- 產品市場收入：依類型劃分（2017-2030 年）
- 設備市場收入：依類型劃分（2017-2030 年）
市場收入：以最終用戶劃分（2017-2030 年）
市場收入：依分銷管道劃分（2017-2030 年）
市場收入：按地區劃分（2017-2030 年）

第7章北美市場

摘要
市場收入：依產品分類（2017-2030 年）
- 產品市場收入：依類型劃分（2017-2030 年）
- 設備市場收入：依類型劃分（2017-2030 年）
市場收入：以最終用戶劃分（2017-2030 年）
市場收入：依分銷管道劃分（2017-2030 年）
市場收入：依國家/地區劃分（2017-2030 年）

第8章歐洲市場

第9章亞太市場

第10章拉丁美洲市場

第11章中東及非洲市場

第12章美國市場

摘要
市場收入：依產品分類（2017-2030 年）
- 產品市場收入：依類型劃分（2017-2030 年）
- 設備市場收入：依類型劃分（2017-2030 年）
市場收入：以最終用戶劃分（2017-2030 年）
市場收入：依分銷管道劃分（2017-2030 年）

第13章加拿大市場

第14章德國市場

第15章法國市場

第16章英國市場

第17章義大利市場

第18章西班牙市場

第19章日本市場

第20章中國市場

第21章印度市場

第22章澳洲市場

第23章韓國市場

第24章巴西市場

第25章墨西哥市場

第26章沙烏地阿拉伯市場

第27章南非市場

第 28 章阿聯酋 (UAE) 市場

第29章競爭態勢

市場參與者及其產品列表
主要公司的競爭基準
各大公司的產品基準
近期策略發展狀況

第30章公司簡介

Bio-Rad Laboratories Inc.
Bruker Corporation
Danaher Corporation
Agilent Technologies Inc.
Merck KGaA
Sartorius AG
Shimadzu Corporation
Thermo Fisher Scientific Inc.

第31章附錄

簡介目錄

Product Code: 12821

Market Overview

The lab supplies industry is valued at USD 40.3 billion in 2023, which is projected to attain USD 66.4 billion by 2030, advancing at a CAGR of 7.6% over the projection period.

This is attributed to the fact that the ongoing research and development on the emergence of these entities have been increased due to the increased spending of life science companies on this aspect, the number of these firms has gone up and the occurrence of infectious conditions is widespread.

Nowadays, the connectivity of innovations in the diagnostic testing sector and scientific instruments to advanced technologies markedly elevated laboratory functionalities. Achievement of these innovative technologies and their processes facilitates open work ground and leads to high precision and efficiency of researchers and lab techs. AI, Automation, smart stands, and analysis tools, as well as the way to miniaturize, have now become indispensable for the lab environment, which makes it easier to handle the processes and gain more accurate outcomes.

As time passes by, results become more and more required and urgent; with this in mind, laboratories must be faster and more efficient. Lab managers can create a more efficient buying process which is the retailer's main margin for survival and this can in turn largely enhance the buying operation. Furthermore, the companies that provide musical instruments and consumables to these facilities are now trying to develop a selection of their products and order procedures that will be convenient for the clients.

Key Insights

The equipment category holds the largest market share of 70% in the lab supplies market in 2023.

This dominance is mainly caused by the established demand of such quality instruments by pharmaceutical and biotechnology companies, R&D centers, labs, and scientific organizations.

These devices are the essential ones for conducting a number of successful experiments, tests and studies.

The instrument quality, strength and durability highly influence the accuracy and speed of the results.

The industry continuously produces appliances that facilitate labor intensity and help achieve perfect results in scientific work.

Research and development centers hold the largest market share of 40% in the end-user segment of the lab supplies market in 2023.

This dominance is attributed to the growing number of research initiatives in the biopharmaceutical, pharmaceutical, and biotechnology industries.

The increasing demand for advanced drugs and tests has fueled the expansion of research and development activities.

Consequently, there is a rising engagement of R&D labs, leading to the significant market share held by this category.

North America leads the sector due to the presence of numerous biopharmaceutical, pharmaceutical, and biotechnology giants actively engaged in R&D.

Research agencies in the region are enhancing their infrastructure with government funding.

The region's major players offer excellent data quality and track records, attracting research funds.

The incidence of serious diseases is quite high and many of these diseases are supported by government and non-government funded drug launches and clinical trials.

Europe is anticipated to boast high growth on the strength of considerable number of research institutions and increasing research grants.

Launching of solid medication safety regulations propels overall quality control activities and consequently promotes a regional market position.

Chapter 1. Research Scope

1.1. Research Objectives
1.2. Market Definition
1.3. Analysis Period
1.4. Market Size Breakdown by Segments
- 1.4.1. Market size breakdown, by offering
- 1.4.2. Market size breakdown, by end user
- 1.4.3. Market size breakdown, by distribution channel
- 1.4.4. Market size breakdown, by region
- 1.4.5. Market size breakdown, by country
1.5. Market Data Reporting Unit
- 1.5.1. Value
1.6. Key Stakeholders

Chapter 2. Research Methodology

2.1. Secondary Research
- 2.1.1. Paid
- 2.1.2. Unpaid
- 2.1.3. P&S Intelligence database
2.2. Primary Research
2.3. Market Size Estimation
2.4. Data Triangulation
2.5. Currency Conversion Rates
2.6. Assumptions for the Study
2.7. Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Market Indicators

Chapter 5. Industry Outlook

5.1. Market Dynamics
- 5.1.1. Trends
- 5.1.2. Drivers
- 5.1.3. Restraints/challenges
- 5.1.4. Impact analysis of drivers/restraints
5.2. Impact of COVID-19
5.3. Porter's Five Forces Analysis
- 5.3.1. Bargaining power of buyers
- 5.3.2. Bargaining power of suppliers
- 5.3.3. Threat of new entrants
- 5.3.4. Intensity of rivalry
- 5.3.5. Threat of substitutes

Chapter 6. Global Market

6.1. Overview
6.2. Market Revenue, by Offering (2017-2030)
- 6.2.1. Product market revenue, by type (2017-2030)
- 6.2.2. Equipment market revenue, by type (2017-2030)
6.3. Market Revenue, by End User (2017-2030)
6.4. Market Revenue, by Distribution Channel (2017-2030)
6.5. Market Revenue, by Region (2017-2030)

Chapter 7. North America Market

7.1. Overview
7.2. Market Revenue, by Offering (2017-2030)
- 7.2.1. Product market revenue, by type (2017-2030)
- 7.2.2. Equipment market revenue, by type (2017-2030)
7.3. Market Revenue, by End User (2017-2030)
7.4. Market Revenue, by Distribution Channel (2017-2030)
7.5. Market Revenue, by Country (2017-2030)

Chapter 8. Europe Market

8.1. Overview
8.2. Market Revenue, by Offering (2017-2030)
- 8.2.1. Product market revenue, by type (2017-2030)
- 8.2.2. Equipment market revenue, by type (2017-2030)
8.3. Market Revenue, by End User (2017-2030)
8.4. Market Revenue, by Distribution Channel (2017-2030)
8.5. Market Revenue, by Country (2017-2030)

Chapter 9. APAC Market

9.1. Overview
9.2. Market Revenue, by Offering (2017-2030)
- 9.2.1. Product market revenue, by type (2017-2030)
- 9.2.2. Equipment market revenue, by type (2017-2030)
9.3. Market Revenue, by End User (2017-2030)
9.4. Market Revenue, by Distribution Channel (2017-2030)
9.5. Market Revenue, by Country (2017-2030)

Chapter 10. LATAM Market

10.1. Overview
10.2. Market Revenue, by Offering (2017-2030)
- 10.2.1. Product market revenue, by type (2017-2030)
- 10.2.2. Equipment market revenue, by type (2017-2030)
10.3. Market Revenue, by End User (2017-2030)
10.4. Market Revenue, by Distribution Channel (2017-2030)
10.5. Market Revenue, by Country (2017-2030)

Chapter 11. MEA Market

11.1. Overview
11.2. Market Revenue, by Offering (2017-2030)
- 11.2.1. Product market revenue, by type (2017-2030)
- 11.2.2. Equipment market revenue, by type (2017-2030)
11.3. Market Revenue, by End User (2017-2030)
11.4. Market Revenue, by Distribution Channel (2017-2030)
11.5. Market Revenue, by Country (2017-2030)

Chapter 12. U.S. Market

12.1. Overview
12.2. Market Revenue, by Offering (2017-2030)
- 12.2.1. Product market revenue, by type (2017-2030)
- 12.2.2. Equipment market revenue, by type (2017-2030)
12.3. Market Revenue, by End User (2017-2030)
12.4. Market Revenue, by Distribution Channel (2017-2030)

Chapter 13. Canada Market

13.1. Overview
13.2. Market Revenue, by Offering (2017-2030)
- 13.2.1. Product market revenue, by type (2017-2030)
- 13.2.2. Equipment market revenue, by type (2017-2030)
13.3. Market Revenue, by End User (2017-2030)
13.4. Market Revenue, by Distribution Channel (2017-2030)

Chapter 14. Germany Market

14.1. Overview
14.2. Market Revenue, by Offering (2017-2030)
- 14.2.1. Product market revenue, by type (2017-2030)
- 14.2.2. Equipment market revenue, by type (2017-2030)
14.3. Market Revenue, by End User (2017-2030)
14.4. Market Revenue, by Distribution Channel (2017-2030)

Chapter 15. France Market

15.1. Overview
15.2. Market Revenue, by Offering (2017-2030)
- 15.2.1. Product market revenue, by type (2017-2030)
- 15.2.2. Equipment market revenue, by type (2017-2030)
15.3. Market Revenue, by End User (2017-2030)
15.4. Market Revenue, by Distribution Channel (2017-2030)

Chapter 16. U.K. Market

16.1. Overview
16.2. Market Revenue, by Offering (2017-2030)
- 16.2.1. Product market revenue, by type (2017-2030)
- 16.2.2. Equipment market revenue, by type (2017-2030)
16.3. Market Revenue, by End User (2017-2030)
16.4. Market Revenue, by Distribution Channel (2017-2030)

Chapter 17. Italy Market

17.1. Overview
17.2. Market Revenue, by Offering (2017-2030)
- 17.2.1. Product market revenue, by type (2017-2030)
- 17.2.2. Equipment market revenue, by type (2017-2030)
17.3. Market Revenue, by End User (2017-2030)
17.4. Market Revenue, by Distribution Channel (2017-2030)

Chapter 18. Spain Market

18.1. Overview
18.2. Market Revenue, by Offering (2017-2030)
- 18.2.1. Product market revenue, by type (2017-2030)
- 18.2.2. Equipment market revenue, by type (2017-2030)
18.3. Market Revenue, by End User (2017-2030)
18.4. Market Revenue, by Distribution Channel (2017-2030)

Chapter 19. Japan Market

19.1. Overview
19.2. Market Revenue, by Offering (2017-2030)
- 19.2.1. Product market revenue, by type (2017-2030)
- 19.2.2. Equipment market revenue, by type (2017-2030)
19.3. Market Revenue, by End User (2017-2030)
19.4. Market Revenue, by Distribution Channel (2017-2030)

Chapter 20. China Market

20.1. Overview
20.2. Market Revenue, by Offering (2017-2030)
- 20.2.1. Product market revenue, by type (2017-2030)
- 20.2.2. Equipment market revenue, by type (2017-2030)
20.3. Market Revenue, by End User (2017-2030)
20.4. Market Revenue, by Distribution Channel (2017-2030)

Chapter 21. India Market

21.1. Overview
21.2. Market Revenue, by Offering (2017-2030)
- 21.2.1. Product market revenue, by type (2017-2030)
- 21.2.2. Equipment market revenue, by type (2017-2030)
21.3. Market Revenue, by End User (2017-2030)
21.4. Market Revenue, by Distribution Channel (2017-2030)

Chapter 22. Australia Market

22.1. Overview
22.2. Market Revenue, by Offering (2017-2030)
- 22.2.1. Product market revenue, by type (2017-2030)
- 22.2.2. Equipment market revenue, by type (2017-2030)
22.3. Market Revenue, by End User (2017-2030)
22.4. Market Revenue, by Distribution Channel (2017-2030)

Chapter 23. South Korea Market

23.1. Overview
23.2. Market Revenue, by Offering (2017-2030)
- 23.2.1. Product market revenue, by type (2017-2030)
- 23.2.2. Equipment market revenue, by type (2017-2030)
23.3. Market Revenue, by End User (2017-2030)
23.4. Market Revenue, by Distribution Channel (2017-2030)

Chapter 24. Brazil Market

24.1. Overview
24.2. Market Revenue, by Offering (2017-2030)
- 24.2.1. Product market revenue, by type (2017-2030)
- 24.2.2. Equipment market revenue, by type (2017-2030)
24.3. Market Revenue, by End User (2017-2030)
24.4. Market Revenue, by Distribution Channel (2017-2030)

Chapter 25. Mexico Market

25.1. Overview
25.2. Market Revenue, by Offering (2017-2030)
- 25.2.1. Product market revenue, by type (2017-2030)
- 25.2.2. Equipment market revenue, by type (2017-2030)
25.3. Market Revenue, by End User (2017-2030)
25.4. Market Revenue, by Distribution Channel (2017-2030)

Chapter 26. Saudi Arabia Market

26.1. Overview
26.2. Market Revenue, by Offering (2017-2030)
- 26.2.1. Product market revenue, by type (2017-2030)
- 26.2.2. Equipment market revenue, by type (2017-2030)
26.3. Market Revenue, by End User (2017-2030)
26.4. Market Revenue, by Distribution Channel (2017-2030)

Chapter 27. South Africa Market

27.1. Overview
27.2. Market Revenue, by Offering (2017-2030)
- 27.2.1. Product market revenue, by type (2017-2030)
- 27.2.2. Equipment market revenue, by type (2017-2030)
27.3. Market Revenue, by End User (2017-2030)
27.4. Market Revenue, by Distribution Channel (2017-2030)

Chapter 28. U.A.E. Market

28.1. Overview
28.2. Market Revenue, by Offering (2017-2030)
- 28.2.1. Product market revenue, by type (2017-2030)
- 28.2.2. Equipment market revenue, by type (2017-2030)
28.3. Market Revenue, by End User (2017-2030)
28.4. Market Revenue, by Distribution Channel (2017-2030)

Chapter 29. Competitive Landscape

29.1. List of Market Players and their Offerings
29.2. Competitive Benchmarking of Key Players
29.3. Product Benchmarking of Key Players
29.4. Recent Strategic Developments

Chapter 30. Company Profiles

30.1. Bio-Rad Laboratories Inc.
- 30.1.1. Business overview
- 30.1.2. Product and service offerings
- 30.1.3. Key financial summary
30.2. Bruker Corporation
- 30.2.1. Business overview
- 30.2.2. Product and service offerings
- 30.2.3. Key financial summary
30.3. Danaher Corporation
- 30.3.1. Business overview
- 30.3.2. Product and service offerings
- 30.3.3. Key financial summary
30.4. Agilent Technologies Inc.
- 30.4.1. Business overview
- 30.4.2. Product and service offerings
- 30.4.3. Key financial summary
30.5. Merck KGaA
- 30.5.1. Business overview
- 30.5.2. Product and service offerings
- 30.5.3. Key financial summary
30.6. Sartorius AG
- 30.6.1. Business overview
- 30.6.2. Product and service offerings
- 30.6.3. Key financial summary
30.7. Shimadzu Corporation
- 30.7.1. Business overview
- 30.7.2. Product and service offerings
- 30.7.3. Key financial summary
30.8. Thermo Fisher Scientific Inc.
- 30.8.1. Business overview
- 30.8.2. Product and service offerings
- 30.8.3. Key financial summary